Jiatian Lin Selected Research

thrombospondin 3

1/2022

Identification of adhesion-associated extracellular matrix component thrombospondin 3 as a prognostic signature for clear cell renal cell carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jiatian Lin Research Topics

Disease

5	Neoplasms (Cancer) 01/2022 - 01/2019
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 01/2022
2	Colorectal Neoplasms (Colorectal Cancer) 12/2020 - 01/2019
1	Carcinoma (Carcinomatosis) 01/2021
1	Urinary Bladder Neoplasms (Bladder Cancer) 08/2019
1	Neoplasm Metastasis (Metastasis) 01/2019
1	Hepatocellular Carcinoma (Hepatoma) 01/2019
1	Inflammation (Inflammations) 01/2019
1	Lymphoma (Lymphomas) 11/2014

Drug/Important Bio-Agent (IBA)

2	Long Noncoding RNAIBA 01/2021 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2019
2	RNA (Ribonucleic Acid)IBA 12/2020 - 01/2019
1	thrombospondin 3IBA 01/2022
1	Small Interfering RNA (siRNA)IBA 12/2020
1	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 08/2019
1	Pharmaceutical PreparationsIBA 01/2019
1	Messenger RNA (mRNA)IBA 01/2019
1	Angiopoietin-Like Protein 2IBA 01/2019
1	Glycoproteins (Glycoprotein)IBA 01/2019
1	Orphan Nuclear ReceptorsIBA 01/2019
1	Member 1 Group A Nuclear Receptor Subfamily 4IBA 01/2019

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 01/2022 - 11/2014
2	Radiotherapy 01/2022 - 01/2021